September 1, 2008Hi-Tech files for decision on drug exclusivity - Forbes Hi-Tech files for decision on drug exclusivity - Forbes
Generic drug developer and nutritional products company Hi-Tech Pharmacal Co. said Thursday it asked a district court to rule that it is eligible for 180 days of market exclusivity for a generic version of Merck 's glaucoma treatment Cosopt. The Source: www.forbes.com GlaxoSmithKline drug ad sparks a debate - Philadelphia Inquirer "DON'T BE FOOLED: GlaxoSmithKline's scare tactics are only concerned with protecting its profit, not the health of people with HIV/AIDS," the ads read. The AIDS Healthcare Foundation (AHF) is running the spots in the Washington Blade, the Village Source: www.philly.com Mylan to launch generic Alzheimer's drug - BusinessWeek Mylan Inc. said Friday it is immediately launching a generic version of the Alzheimer's disease drug Razadyne after receiving regulatory approval and a favorable court ruling. The original drug is made by Ortho-McNeil Neurologics, a unit of Johnson Source: www.businessweek.com Salmonella outbreak appears to be over, CDC says - Houston Chronicle WASHINGTON — The Centers for Disease Control and Prevention say the salmonella outbreak that sickened more than 1,440 people appears to be over. A joint investigation by CDC and the Food and Drug Administration found strong evidence that jalapeno Source: www.chron.com Debate over food irradiation still simmering - Minneapolis Star Tribune A fter two years of nearly constant food-borne illness outbreaks and recalls of everything from tainted peanut butter to tons of hamburger meat, the Food and Drug Administration's decision this month to allow the irradiation of lettuce and spinach to Source: www.startribune.com # posted by Network @ 4:00 PM
 |
Subscribe to Posts [Atom]